Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Gabriel EM, Kim M, Fisher DT, et al. A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis. Sci Rep. 2021;11:4946.
2. Kitayama J, Ishigami H, Yamaguchi H, et al. Optimal drug delivery for intraperitoneal paclitaxel (PTX) in murine model. Pleura Peritoneum. 2017;2:95–102.
3. Yamaguchi H, Kitayama J, Ishigami H, et al. Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: intraperitoneal chemotherapy with taxanes. World J Gastrointest Oncol. 2015;7:285–91.
4. Jang SH, Wientjes MG, Au JL. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. J Pharmacol Exp Ther. 2001;296:1035–42.
5. Ishigami H, Kitayama J, Kaisaki S, et al. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010;21:67–70.